Myelodysplastic syndrome
Conditions
Interventions
Sponsors
Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet the mds-rcmd western medicine diagnosis and typing standard; (2) Those who meet the criteria of deficiency of spleen and kidney and blocking of toxin and blood stasis in traditional Chinese medicine; (3) The age of the patients ranged from 18 to 80 years; (4) The patient gave informed consent, voluntarily participated in the medication, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Combined with other serious hematological diseases, such as paroxysmal nocturnal hemoglobinuria, acute hematopoietic stagnation, bone marrow proliferative diseases, etc; (2) Hereditary blood system diseases (including immediate relatives within three generations); (3) Pregnant and lactating women, patients with reproductive needs or allergic constitution; (4) Severe heart, liver and kidney dysfunction: serum creatinine was higher than the upper limit of normal value; Alanine aminotransferase, aspartase and bilirubin were 2 times higher than the normal value; NYHA grade = class II; Or patients with neurological diseases; (5) Taking other traditional Chinese medicine or participating in other clinical studies one month before treatment may have an impact on the efficacy observation indicators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal ultrasound;routine blood test;electrocardiogram;Liver and kidney function;Bone marrow cytology; | — |
Countries
China
Contacts
Public ContactTang Xudong
Outcome results
None listed